logo
logo

Ai Startup Lunit Secures Investment From Guardant Health In A Strategic Funding Round

Ai Startup Lunit Secures Investment From Guardant Health In A Strategic Funding Round

07/19/21, 1:37 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/KR.svgseoul
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of $26 million from Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company.

Company Info

Company
Lunit
Location
seoul, seoul, south korea
Additional Info
Through AI, Lunit aims to make data-driven medicine the new standard of care. Lunit is an AI software company devoted to developing AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients. We are especially focused on conquering cancer, one of the leading causes of death worldwide. Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Our technology has been recognized at international AI competitions surpassing top companies like Google, IBM, and Microsoft. As a medical AI company that values building clinical evidence, our findings are presented in major peer-reviewed journals and global conferences including ASCO and AACR. Lunit is headquartered in Seoul, South Korea with offices and representatives in the U.S.A., Netherlands, and China.